Trial Profile
IMPAACT P1058A: Intensive Pharmacokinetic Studies of New Classes of Antiretroviral Drug Combinations in Children, Adolescents and Young Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Maraviroc (Primary) ; Raltegravir (Primary) ; Atazanavir; Darunavir; Lopinavir/ritonavir; Rilpivirine; Ritonavir; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacokinetics
- 31 Aug 2016 Results from patients treated with Atazanavir (n=18) published in the Pediatric Infectious Disease Journal
- 16 May 2016 Results of pharmacokinetics of rilpivirine with and without darunavir/ritonavir (n=28) published in the Pediatric Infectious Disease Journal
- 16 May 2014 Status changed from active, no longer recruiting to completed.